Screener
Crinetics Pharmaceuticals CRNX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock, $0.001 par; 10,000 shares authorized; no shares issued or outstanding at March 31, 2026 or December 31, 2025 | — | — |
| Common stock and paid-in capital, $0.001 par; 200,000 shares authorized; 105,314 shares issued and outstanding at March 31, 2026; 95,575 shares issued and outstanding at December 31, 2025 | 2,828,204 | 2,407,757 |
| Accumulated other comprehensive (loss) income | (1,254) | 1,865 |
| Accumulated deficit | (1,545,272) | (1,417,427) |
| Stock held in trust | (1,032) | (112) |
| TOTAL STOCKHOLDERS’ EQUITY | 1,280,646 | 992,083 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $1,401,323 | $1,126,257 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Crinetics Pharmaceuticals's retained earnings?
- Crinetics Pharmaceuticals (CRNX) reported retained earnings of -$1.55B in Q1 2026.
- How has Crinetics Pharmaceuticals's retained earnings changed year-over-year?
- Crinetics Pharmaceuticals's retained earnings decreased by 47.3% year-over-year, from -$1.05B to -$1.55B.
- What is the long-term trend for Crinetics Pharmaceuticals's retained earnings?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's retained earnings has grown at a 53.3% compound annual growth rate (CAGR), from -$167.61M to -$1.42B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Crinetics Pharmaceuticals's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude